Condition
NSCLC, Stage I clinical trials and research
As of November 12, 2026, Find a Trial lists 5 NSCLC, Stage I clinical trials that are recruiting, at sites in 3 countries (most in United States (2), China (2), Italy (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest NSCLC, Stage I clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BIO 300 with thoracic radiation for early-stage non-small cell lung cancer and interstitial lung disease | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jan 7, 2026 |
| Understanding the diagnosis and treatment of early and locally advanced non-small cell lung cancer | — | San Giovanni Rotondo, FG and 24 other locations | Recruiting | Jun 21, 2024 |
| Navigating lung nodules for resection using a new mapping technique | — | Guangzhou, Guangdong | Recruiting | May 8, 2024 |
| Osimertinib treatment after surgery for high-risk stage I lung cancer | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Jan 17, 2023 |
| Comparing Pembrolizumab to Observation after Surgery for Stage I Lung Cancer | Phase 2 | Tampa, Florida and 12 other locations | Recruiting | Mar 23, 2020 |
All recruiting trials (5)
-
BIO 300 with thoracic radiation for early-stage non-small cell lung cancer and interstitial lung disease
This trial will test whether adding BIO 300 to thoracic radiation lowers the chance of pneumonitis in people with stage I–II non-small cell lung cancer who also have interstitial lung disease.
-
Understanding the diagnosis and treatment of early and locally advanced non-small cell lung cancer
This study looks at how patients with early and locally advanced non-small cell lung cancer are diagnosed and treated after surgery or radiation to see how well different approaches work.
-
Navigating lung nodules for resection using a new mapping technique
This study is testing a new way to locate small lung nodules during surgery to see if it helps patients with early-stage lung cancer recover faster and have better outcomes.
-
Osimertinib treatment after surgery for high-risk stage I lung cancer
This study is testing if taking Osimertinib after surgery can help people with high-risk stage I lung cancer stay cancer-free longer.
-
Comparing Pembrolizumab to Observation after Surgery for Stage I Lung Cancer
This study is testing if the drug Pembrolizumab can help people with stage I lung cancer stay cancer-free longer after surgery compared to just being monitored.
Related topics
Quick answers
How many NSCLC, Stage I clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), China (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.